Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1985-1989  (2)
  • Benzodiazepine antagonist  (1)
  • Hemofiltration  (1)
  • 1
    ISSN: 1432-1238
    Keywords: Head injury ; Intracranial pressure ; Midazolam ; Benzodiazepine antagonist ; RO 15-1788
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract In patients with severe head injury, midazolam is a convenient agent for sedation during mechanical ventilation, although its sedative effect can be prolonged. We investigated the effects of acute midazolam reversal by RO 15-1788 (RO), a benzodiazepine antagonist, on intracranial pressure (ICP), cerebral perfusion pressure (CPP) and on recovery in 18 studies performed on 15 patients with severe head injury (Glasgow coma score〈8). ICP increased significantly from 16.3 mmHg±2 (mean ±SEM) to 24.1 mmHg±4.2 (p〈0.02) and to 25.2 mmHg±4 (p〈0.01), 5 and 10 min respectively after RO administration. Analysis of the results showed 2 patterns of response in ICP. In patients with good control of ICP before RO administration, there was no change in ICP and CPP, whereas in patients with abnormal ICP, RO injection induced severe increase in ICP and concomitant decrease in CPP. Arousal after midazolam reversal was obvious in 5 patients who were quickly extubated. Midazolam reversal by RO should not be attempted in patients with severe head injury and unstable ICP.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 14 (1988), S. 236-237 
    ISSN: 1432-1238
    Keywords: Hemofiltration ; Flecainide ; Atrial fibrillation ; Pharmacokinetics ; Renal failure
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Flecainide, a new antiarrhythmic drug, has been shown not no be removed to a significant extent by hemodialysis or peritoneal dialysis, in spite of a high renal clerance. Its systemic and hemofiltrate clearances, measured in a patient under continuous hemofiltration, were 402 and 19.7 ml/min respectively. The clearance ratio of less than 5% makes the contribution of hemofiltration to the elimination of flecainide clinically negligeable.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...